Literature DB >> 26363073

Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-κB Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-κB Signaling through Cleavage of TANK.

Li Huang1, Qinfang Liu1, Lijie Zhang1, Quan Zhang2, Liang Hu1, Changyao Li1, Shengnan Wang1, Jiangnan Li1, Yuanfeng Zhang1, Huibin Yu1, Yan Wang3, Zhaohua Zhong4, Tao Xiong5, Xueshan Xia6, Xiaojun Wang1, Li Yu1, Guohua Deng1, Xuehui Cai1, Shangjin Cui7, Changjiang Weng8.   

Abstract

TRAF family member-associated NF-κB activator (TANK) is a negative regulator of canonical NF-κB signaling in the Toll-like receptor- and B-cell receptor-mediated signaling pathways. However, functions of TANK in viral infection-mediated NF-κB activation remain unclear. Here, we reported that TANK was cleaved by encephalomyocarditis virus 3C at the 197 and 291 glutamine residues, which depends on its cysteine protease activity. In addition, encephalomyocarditis virus 3C impaired the ability of TANK to inhibit TRAF6-mediated NF-κB signaling. Interestingly, we found that several viral proteases encoded by the foot and mouth disease virus, porcine reproductive and respiratory syndrome virus, and equine arteritis virus also cleaved TANK. Our results suggest that TANK is a novel target of some viral proteases, indicating that some positive RNA viruses have evolved to utilize their major proteases to regulate NF-κB activation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NF-kappa B (NF-KB); cell signaling; immunology; viral protease; virus

Mesh:

Substances:

Year:  2015        PMID: 26363073      PMCID: PMC4646013          DOI: 10.1074/jbc.M115.660761

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Viral protease cleavage of inhibitor of kappaBalpha triggers host cell apoptosis.

Authors:  Carlos Zaragoza; Marta Saura; Elizaveta Y Padalko; Ester Lopez-Rivera; Tania R Lizarbe; Santiago Lamas; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-30       Impact factor: 11.205

2.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

Review 3.  Regulation and function of IKK and IKK-related kinases.

Authors:  Hans Häcker; Michael Karin
Journal:  Sci STKE       Date:  2006-10-17

4.  NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.

Authors:  J L Pomerantz; D Baltimore
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

5.  Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.

Authors:  Jean-Stéphane Gatot; Romain Gioia; Tieu-Lan Chau; Félicia Patrascu; Michael Warnier; Pierre Close; Jean-Paul Chapelle; Eric Muraille; Keith Brown; Ulrich Siebenlist; Jacques Piette; Emmanuel Dejardin; Alain Chariot
Journal:  J Biol Chem       Date:  2007-09-06       Impact factor: 5.157

6.  TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB.

Authors:  Masashi Muroi; Ken-ichi Tanamoto
Journal:  J Leukoc Biol       Date:  2007-12-10       Impact factor: 4.962

Review 7.  Signaling to NF-kappaB by Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Trends Mol Med       Date:  2007-10-29       Impact factor: 11.951

Review 8.  The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.

Authors:  Luke A J O'Neill
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

9.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

10.  TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.

Authors:  Matthew C Walsh; Gregory K Kim; Paul L Maurizio; Elizabeth E Molnar; Yongwon Choi
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more
  19 in total

1.  Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.

Authors:  Yajuan Rui; Jiaming Su; Hong Wang; Junliang Chang; Shaohua Wang; Wenwen Zheng; Yong Cai; Wei Wei; James T Gordy; Richard Markham; Wei Kong; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Porcine Sapelovirus 3Cpro Inhibits the Production of Type I Interferon.

Authors:  Mengge Yin; Wei Wen; Haoyuan Wang; Qiongqiong Zhao; Hechao Zhu; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

3.  Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.

Authors:  Suhong Qian; Wenchun Fan; Tingting Liu; Mengge Wu; Huawei Zhang; Xiaofang Cui; Yun Zhou; Junjie Hu; Shaozhong Wei; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

4.  Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study.

Authors:  Jian-Jun Li; Jie Luo; Jing-Ning Lu; Xiao-Na Liang; Yi-Huan Luo; Yong-Ru Liu; Jie Yang; Hua Ding; Gui-Hui Qin; Li-Hua Yang; Yi-Wu Dang; Hong Yang; Gang Chen
Journal:  Cancer Cell Int       Date:  2016-09-29       Impact factor: 5.722

Review 5.  Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments.

Authors:  Katharina S Schulz; Karen L Mossman
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

6.  A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.

Authors:  Bingqing Li; Yingying Yue; Yajie Zhang; Zenglin Yuan; Peng Li; Nannan Song; Wei Lin; Yan Liu; Lichuan Gu; Hong Meng
Journal:  Front Cell Infect Microbiol       Date:  2017-02-03       Impact factor: 5.293

7.  Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKKε-IRF3 complex.

Authors:  Li Huang; Tao Xiong; Huibin Yu; Quan Zhang; Kunli Zhang; Changyao Li; Liang Hu; Yuanfeng Zhang; Lijie Zhang; Qinfang Liu; Shengnan Wang; Xijun He; Zhigao Bu; Xuehui Cai; Shangjin Cui; Jiangnan Li; Changjiang Weng
Journal:  Biochem J       Date:  2017-06-09       Impact factor: 3.857

Review 8.  Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.

Authors:  Miguel Rodríguez Pulido; Margarita Sáiz
Journal:  Front Cell Infect Microbiol       Date:  2017-06-13       Impact factor: 5.293

9.  gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK.

Authors:  Bin Wang; Mengjiao Fu; Yanan Liu; Yongqiang Wang; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  Front Cell Infect Microbiol       Date:  2018-03-07       Impact factor: 5.293

10.  Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.

Authors:  Wei Wang; Yan Zheng; Jinjing Jia; Changji Li; Qiqi Duan; Ruilian Li; Xin Wang; Yongping Shao; Caifeng Chen; Huling Yan
Journal:  Exp Ther Med       Date:  2017-06-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.